Smith & Nephew Plc SNN 深 滬
等待開盤 11-05 09:30:00 美东时间
37.02
+0.250
+0.68%
華盛通- 最 高37.08
- 今 開36.48
- 成交量 70.71万股
- 最 低 36.46
- 昨 收 36.77
- 總市值 156.96亿
- 52周最高 38.505
- 市盈率 靜 39.34
- 換手率 0.17%
- 52周最低 22.958
- 委 比 -80.59%
- 總股本 4.24亿
- 歷史最高 47.883
- 量 比 1.82
- 振 幅 1.69%
- 歷史最低 8.893
- 每 手 1
- 風險率 4.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Smith+Nephew Study Finds PICO sNPWT (-80 mmHg) Outperforms Prevena (-125 mmHg) In Reducing Wound Complications, Hospital Stay, And Costs In Orthopedic And Cardiovascular Surgeries
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices
10-27 23:38
BlackRock Increases Stake in Smith & Nephew
Smith & Nephew Snats ( ($SNN) ) has issued an update. On October 22, 2025, ...
10-24 00:57
UFC® and Smith+Nephew announce multi-year extension of partnership
Smith+Nephew and UFC have extended their global marketing partnership until 2026, focusing on sports medicine technology for injury prevention and recovery. Smith+Nephew will continue as UFC’s Preferred Sports Medicine Technology Partner, host medical education courses, and engage UFC athletes as brand ambassadors. The partnership aims to enhance health and safety in combat sports using advanced technologies like the REGENETEN and CARTIHEAL impla...
10-22 15:30
Smith & Nephew Releases Six-Monthly Block Listing Return
An update from Smith & Nephew Snats ( ($SNN) ) is now available. On October...
10-16 21:27
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
10-15 18:20
BlackRock Adjusts Voting Rights in Smith & Nephew
Smith & Nephew Snats ( ($SNN) ) has shared an update. On October 13, 2025, ...
10-15 00:47
Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target
Bernstein analyst Lisa Clive downgrades Smith & Nephew (NYSE:SNN) from Outperform to Market Perform and announces $37.5 price target.
10-14 20:49
J&J rises after guidance boost: plans to separate orthopaedics unit
Johnson & Johnson (NYSE:JNJ) traded higher in the premarket on Tuesday after the New Brunswick, New Jersey-based company kicked off the healthcare earnings season, reporting better-than-expected resul...
10-14 18:44
Smith+Nephew to Host Capital Markets Days in December 2025
An announcement from Smith & Nephew Snats ( ($SNN) ) is now available. Smit...
10-08 19:17
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention
Smith+Nephew announced new data from Professor Amit Gefen’s research group showing that the ALLEVYN COMPLETE CARE Foam Dressing can absorb 93% of mechanical energy, helping reduce pressure injuries by dissipating shear forces. Pressure injuries cost the U.S. healthcare system over $26.8 billion annually. The dressing’s advanced biomechanical performance targets harmful stress concentrations, and it will be launched in the U.S. market later this y...
10-03 15:53
